About · Vynta

The Gold Standard in
Cellular Biotechnology.

Welcome to Vynta, where regenerative science meets molecular purity. We are leaders in cellular solutions, offering a premium catalog of allogeneic stem cells, exosome formulations, and bioactive peptides processed under the most demanding global quality standards. Our reputation is built on reliability, constant innovation, and flawless technical support, establishing us as the definitive choice for those seeking excellence in biological optimization.

Vynta · est. 2018Operating

A regenerative medicine house built around three families — allogeneic cells, pure exosomes, and therapeutic peptides — manufactured under GMP at Celgenic Labs, Florida.

2018
Founded · Miami
GMP
Celgenic Labs · FL
15
SKUs in catalog
47
Clinical partners
01 · What we make03 pillars

Three families. One operating standard.

Allogeneic stem cells, exosome formulations, and bioactive peptides — each built around the same GMP pipeline, the same lot-release process, and the same commitment to clinical-grade quality.

  • 01Allogeneic

    A premium selection of cord-blood-derived stem cells.

    Allogeneic units developed to support and enhance regenerative medicine practice. Our stem cells are sourced and processed under rigorous quality standards to ensure the highest levels of safety and efficacy — essential for professionals delivering advanced treatments and improving patient outcomes.

    • Wharton’s-Jelly source · closed-system GMP
    • Viability ≥ 98.0% across the line
    • Dose options from 30M up to flagship 100M
    Explore allogeneicMSC-PRO · MSC-050 · MSC-030 · MSC-UNI
    Allogeneic — Vynta
    Allogeneic
    Family · 01
    Allogeneic
    Vynta
  • 02Exosomes

    Pure extracellular vesicles, isolated and validated.

    Exosomes are cell-derived nanoparticles at the center of intercellular communication — transferring proteins, mRNA, miRNA and other bioactive molecules between cells, and regulating gene expression in recipients. We isolate them at high purity through tangential-flow concentration and validate every lot by NTA and protein-marker panel.

    • ExoElite 70 — 70 billion particles per vial
    • Celgenic Flow — 30 billion routine workhorse
    • Purity ≥ 99.0% · CD9 · CD63 · CD81 verified
    Explore exosomesEXO-070 · EXO-030
    Exosomes — Vynta
    Exosomes
    Family · 02
    Exosomes
    Vynta
  • 03Peptides

    Therapeutic peptide stacks for the modern protocol.

    A wide range of peptides designed to support diverse biological processes — promoting healing, regeneration, mitochondrial conditioning and endocrine signaling. Rigorously tested for efficacy and safety, with single-target compounds and multi-compound stacks built for clinical use.

    • BPC-157 · TB-500 · GHK-Cu · Ipamorelin · Tesamorelin
    • SS-31 mitochondrial · Epithalon · Tirzepatide
    • Lyophilized · multi-dose · purity ≥ 99.0%
    Explore peptidesPEP-CHR · PEP-AEG · PEP-AUR · PEP-AXS · PEP-AND
    Peptides — Vynta
    Peptides
    Family · 03
    Peptides
    Vynta
02 · ManufacturingGMP · FDA-registered

Unparalleled
manufacturing quality.

Every Vynta product is produced at Celgenic Labs, a GMP-certified facility in Florida, USA. The same closed-system pipeline runs from raw donor source to released vial — short cold-chain, lot-traced, and shipped from Miami in days.

GMP
Certified pipeline
USP <71>
Sterility compliant
−196°C
Vapor-phase LN₂
≤ 4h
Specialist response
  1. Pipeline · Celgenic Labs · FLLive
  2. 01

    Source

    Wharton’s-Jelly cord blood from screened, consented donors. Pre-release viral and microbial panel passed before any cell touches the line.

  3. 02

    Expand

    Closed-system bioreactor expansion through P3 in xeno-free media. Inline metabolite monitoring keeps every lot inside a tight viability envelope.

  4. 03

    Isolate

    Tangential-flow filtration concentrates exosomes; ultracentrifugation polishes purity. NTA + western blot confirm CD9 · CD63 · CD81 markers.

  5. 04

    Release

    USP <71> sterility, endotoxin and mycoplasma checks. Certificate of Analysis travels with every vial. Cryopreserved at −196°C in vapor-phase LN₂.

04 · Forward

Advancing
regenerative
medicine.

Isolating the beneficial signals emitted by stem cells, and using them in place of the cells themselves, is the next generation of regenerative medicine. Exosomes — masters of communication in cellular processes — sit at the center of that shift, and Vynta is built to deliver them at clinical scale.

The crucial role of exosomes in intercellular communication and gene regulation makes them an essential tool for influencing molecular pathways across cardiac, oncology, derm, ortho and reproductive medicine.

Talk to VyntaMon–Fri · 9–18 ET

We're happy to clarify any doubt about protocols, lot specs, custom orders, or distribution. Our regenerative medicine team in Miami typically replies within four hours.

Request a consultationTypical response < 4h